Home News Company news...
March 28, 2024

MEBO Advances Burn Care at Burn and Wound Management Association 9th

On March 27, 2024, MEBO International participated in Burn and Wound Management Association 9th in Thailand, attended by over 400 specialists from East and Southeast Asia. Dr. Apichai Angspatt chaired this authoritative gathering, which spotlighted acute burn treatment, wound care, and chronic wound management.

Experts, including Thailand's renowned Dr. Pomprom, detailed the clinical benefits of MEBT, emphasizing its role in infection control, wound healing rates, and scar prevention. Dr. Angspatt praised MEBO for its pioneering approach to burn and wound care, noting its three-decade legacy of acclaim in Thailand among consumers and medical professionals.

Further enriching its ties, MEBO’s delegation visited Bangkok to meet with DKSH, Thailand's largest pharmaceutical distributor and a long-standing partner, to discuss market trends. This collaboration continues to position MEBO’s products as essential components in Thai first aid kits, reinforcing its commitment to enhancing global burn care practices through innovative treatments and international partnerships.



About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, Mebo Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, Mebo focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, Mebo's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.


About MEBO and Thailand

In 1990, a major gas explosion in Bangkok prompted Professor Rongxiang Xu of MEBO International to lead a successful rescue mission, earning special commendation from the Thai King and government. This event marked the beginning of a lasting relationship between MEBO and Thailand.

In 1995, MEBO became the first Chinese traditional medicine to be registered as a modern pharmaceutical in Thailand, setting a precedent in the country's medical community.

Since 2009, MEBO has accelerated its expansion into the Thai market, conducting extensive regenerative medicine training for over 4,000 medical professionals across 150 hospitals in Bangkok, Khon Kaen, and Chiang Mai. These efforts are part of a broader strategy to deepen engagement with local healthcare providers and distributors like DKSH, with whom MEBO has strengthened ties to expand its reach to over 3,000 pharmacies and 1,000 public and private hospitals in Thailand.

MEBO is not only expanding its product offerings but is also actively engaged in launching innovative regenerative medical products in the Thai market.